NCT02289365 2016-06-15
Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients
Joben Bio-Medical Co., Ltd.
Phase 2 Unknown
Clinical Trials
3 trialsNCT02729324 2016-04-06
Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT
Sun Yat-sen University
Phase 2 Unknown
NCT00445250 2007-03-08
The Role of Calcipotriol as Radioprotector of Skin
Rabin Medical Center
Phase 2 Unknown